Axis Bioservices Limited is a preclinical contract research organisation (CRO) located in Northern Ireland with specialist capabilities in oncology, inflammation and respiratory diseases.
We offer bespoke scientific models to test novel therapeutics for the treatment of illnesses including, but not limited to, breast cancer, lung cancer, prostate cancer, arthritis and chronic obstructive pulmonary disease (COPD).
Services range from in-vitro efficacy and mechanistic studies to in-vivo target engagement with each study tailored to the unique requirements of the client.
Our clients are spread across the globe and include pharmaceutical and biotechnology businesses, university-based research organisations and virtual/semi-virtual development companies.
Company Details
- Employees
- 14
- Founded
- -
- Address
- 189 Castleroe Road, Coleraine,northern Ireland Bt51 3,united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.axisbio.co.uk
- Keywords
- TUMOUR BIOLOGY, COPD, FACS, COMPLETE BLOOD ANALYSIS, INFLAMMATION, IN VITRO ASSAYS, IMMUNO ONCOLOGY.
- HQ
- Coleraine, Northern Ireland
Axis Bioservices Limited Questions
Axis Bioservices Limited's website is http://www.axisbio.co.uk
Axis Bioservices Limited's LinkedIn profile is https://uk.linkedin.com/company/axisbioservices
Axis Bioservices Limited has
14 employees.
View email and phone details for 14
employees at Axis Bioservices Limited.
Axis Bioservices Limited's industry is
Pharmaceutical Manufacturing
Axis Bioservices Limited's top competitors are
Axisbio Diagnostics Sdn. Bhd.,
Diaceutics Plc,
Medinect Ophtho,
Proaxsis,
Cv6 Therapeutics, (Ni) Ltd.,
Celerion,
Amply Discovery,
Ailsebio,
Fusion Antibodies,
Phion Therapeutics.
Axis Bioservices Limited's categories are Pharmaceutical Manufacturing
Axis Bioservices Limited's founding year is 2013
